Quantcast
Last updated on April 18, 2014 at 21:21 EDT

Latest Osteoarthritis Stories

2013-05-06 23:20:18

Diagnostics Research Group is seeking individuals with osteoarthritis for an upcoming study. (PRWEB) May 06, 2013 Diagnostics Research Group, an independent site for pharmaceutical and device research, is working with pharmaceutical companies to assess osteoarthritis (OA) medications currently not available to the public. Osteoarthritis is the most common form of arthritis and affects an estimated 27 million Americans. OA occurs when a joint´s cartilage breaks down. The absence of...

2013-05-02 12:28:39

GERMANTOWN, Md., May 2, 2013 /PRNewswire/ -- RNL BIO, a stem cell biotechnology company dedicated to the commercialization of autologous cell therapy products for a variety of degenerative, ischemic and other indications, has announced that it has filed an Investigational New Drug application (IND) with the Food and Drug Administration (FDA) to begin clinical trials with its adipose-derived stem cell product, termed RNL-JointStem, for the treatment of osteoarthritis (OA). Assuming approval of...

2013-05-01 08:29:53

ATLANTA, May 1, 2013 /PRNewswire-USNewswire/ -- The Arthritis Foundation is announcing a new multiyear public awareness campaign in conjunction with Arthritis Month this May to debunk the myths of arthritis. The Faces of Arthritis campaign will feature public service ads focusing on the harsh realities of arthritis and dispelling the common stereotypes often associated with the disease. (Photo: http://photos.prnewswire.com/prnh/20130501/DC04740) As the nation's leading cause of...

2013-04-25 08:34:34

GREENWOOD VILLAGE, Colo., April 25, 2013 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NASDAQ: AMPE) today announced the completion of patient enrollment in a dose-escalation run-in study to a Phase III pivotal trial evaluating Ampion in the treatment of moderate to severe osteoarthritis of the knee. Twelve week primary endpoint data are expected in the third quarter of 2013. (Logo: http://photos.prnewswire.com/prnh/20120516/MM09116LOGO) In the SPRING trial, Ampion is being evaluated for...

2013-04-24 08:30:41

NORWALK, Conn., April 24, 2013 /PRNewswire/ -- UBM Medica US announces that Musculoskeletal Network features exclusive coverage of the Osteoarthritis Research Society International (OARSI), concluded on Sunday, April 21, in Philadelphia. OARSI is the premier international organization for scientists and health care professionals focused on the prevention and treatment of osteoarthritis (OA). The latest reports from the world's top researchers in osteoarthritis include new support...

2013-04-19 23:19:58

To better understand the onset and progression of osteoarthritis, Nadeen Chahine, PhD, and collaborators at other institutions looked at cells from articular cartilage using atomic force microscopy (AFM). MANHASSET, NY (PRWEB) April 19, 2013 A researcher at The Feinstein Institute for Medical Research has discovered additional mechanical properties of articular cartilage, a protective cartilage on the ends of bones that wears down over time, resulting in the development of osteoarthritis....

2013-04-19 17:54:00

Wearing a knee brace has been shown to “significantly improve the pain and symptoms” of a type of osteoarthritis affecting the kneecap, according to a new study. Arthritis Research UK-funded researchers at The University of Manchester claim their findings, presented at the Osteoarthritis Research Society International meeting in Philadelphia tomorrow (Friday April 19) have enormous potential for treating this common joint condition effectively — as well as providing a...

2013-04-18 16:27:48

WOBURN, Mass., April 18, 2013 /PRNewswire/ -- Flexion Therapeutics, Inc. announced today the presentation of a poster titled "FX006 prolongs the residency of triamcinolone acetonide in the synovial tissues of patients with knee osteoarthritis" at Osteoarthritis Research Society International's (OARSI) 2013 World Congress on Osteoarthritis in Philadelphia. Flexion co-founder and chief medical officer, Neil Bodick, M.D., Ph.D., will discuss the findings during the poster session from 3:30 p.m....

High-Impact Activities Can Damage Cartilage
2013-04-18 05:04:02

Jason Pierce, MSN, MBA, RN for redOrbit.com — Your Universe Online A new paper published in the Biophysical Journal explains why cartilage may be more susceptible to damage from high impact physical activities such as jumping or running during the early stages of osteoarthritis. The results could lead to early diagnostic tests or new designs for replacement cartilage. Cartilage can be found in the joints between bones. It is a flexible tissue protecting the bones from rubbing...

2013-04-15 20:22:19

ATLANTA, April 15, 2013 /PRNewswire-USNewswire/ -- The Arthritis Foundation announces the appointment of John Vernachio, Ph.D. as vice president of research effective April 15. In his new role he will provide leadership and direction to further the Arthritis Foundation research program and the organization's commitment to finding a cure and better, safer treatments for the nation's leading cause of disability. Vernachio will succeed Dr. John Hardin, who will assume a new role within the...